Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Carcinoma Cervix”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06456112
What this trial is testing

Construction and Validation of a Diagnostic Model for Predicting Molecular Residual Disease and Recurrence of Cervical Cancer Based on Circulating Tumor HPV

Who this might be right for
Cervical Cancer
Anhui Provincial Hospital 83
Testing effectiveness (Phase 2)Study completedNCT00002813
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group 62
Testing effectiveness (Phase 2)Looking for participantsNCT06670911
What this trial is testing

Low-dose Pembrolizumab Plus Chemotherapy for the First-Line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer.

Who this might be right for
Persistent, Recurrent, or Metastatic Cervical Cancer
Instituto Nacional de Cancer, Brazil 44
Early research (Phase 1)Study completedNCT00082823
What this trial is testing

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Cancer
Regeneron Pharmaceuticals 25
Not applicableStudy completedNCT02578888
What this trial is testing

Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies

Who this might be right for
Cervical CarcinomaOvarian CarcinomaPrimary Peritoneal Carcinoma+7 more
Albert Einstein College of Medicine 95
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04889742
What this trial is testing

Hyperthermia Enhanced Re-irradiation of Loco-regional Recurrent Tumors

Who this might be right for
Recurrent CancerProstate CancerCervical Cancer+7 more
Charite University, Berlin, Germany 110
Large-scale testing (Phase 3)Study completedNCT00803062
What this trial is testing

Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma+2 more
National Cancer Institute (NCI) 452
Testing effectiveness (Phase 2)UnknownNCT02492503
What this trial is testing

Effectiveness of Chemotherapy in Metastatic or Recurrent Carcinoma Cervix

Who this might be right for
Metastatic Carcinoma to the Uterine CervixRecurrent Carcinoma CervixCervix Carcinoma Recurrent
All India Institute of Medical Sciences 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07363330
What this trial is testing

A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer

Who this might be right for
Cervical CancerRecurrentMetastatic
Zhongnan Hospital 32
Large-scale testing (Phase 3)Active Not RecruitingNCT04906993
What this trial is testing

Camrelizumab Combined With Famitinib Malate for Treatment of Recurrent/Metastatic Cervical Cancer

Who this might be right for
Cervical Cancer
Jiangsu HengRui Medicine Co., Ltd. 443
Testing effectiveness (Phase 2)UnknownNCT02482740
What this trial is testing

A Trial of Tamoxifen and Letrozole in Recurrent and Persistent Squamous Cell Carcinoma of the Cervix

Who this might be right for
Uterine Cervical Neoplasms
Buddhist Tzu Chi General Hospital 44
Not applicableNot Yet RecruitingNCT06155422
What this trial is testing

A Prospective Real-world Study of Cadonilimab in Patients With Recurrent or Metastatic Cervical Cancer

Who this might be right for
Recurrent or Metastatic Cervical Cancer
Gang Chen (101199) 670
Testing effectiveness (Phase 2)Ended earlyNCT04230954
What this trial is testing

Cabozantinib Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical Cancer

Who this might be right for
Cervical CancerRecurrent Cervical CancerMetastatic Cervical Cancer+1 more
University of South Alabama 5
Testing effectiveness (Phase 2)Looking for participantsNCT06266338
What this trial is testing

Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix)

Who this might be right for
Cervix CancerCervical Cancer
University of Texas Southwestern Medical Center 30
Testing effectiveness (Phase 2)UnknownNCT00997009
What this trial is testing

Study of Adding Cetuximab to Chemotherapy for the Treatment of Advanced and/or Recurrent Cervical Cancer

Who this might be right for
Cervical Cancer
National Cancer Institute, Naples 108
Testing effectiveness (Phase 2)Study completedNCT04300647
What this trial is testing

Tiragolumab Plus Atezolizumab and Atezolizumab Monotherapy in Participants With Metastatic and/or Recurrent PD-L1-Positive Cervical Cancer

Who this might be right for
Cervical Cancer
Hoffmann-La Roche 172
Early research (Phase 1)Active Not RecruitingNCT05527184
What this trial is testing

First in Human Study of IMGN151 in Recurrent Gynaecological Cancers

Who this might be right for
Endometrial CancerHigh Grade Serous Adenocarcinoma of OvaryPrimary Peritoneal Carcinoma+2 more
AbbVie 256
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07172217
What this trial is testing

The Efficacy and Safety RC48 Plus QL1706 in Second-Line Treatment of HER2-Expressing Recurrent CC

Who this might be right for
Recurrent Cervical Cancer
Qilu Hospital of Shandong University 33
Testing effectiveness (Phase 2)Study completedNCT00101192
What this trial is testing

Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group 76
Testing effectiveness (Phase 2)Study completedNCT02172911
What this trial is testing

INO-3112 DNA Vaccine With Electroporation in Participants With Cervical Cancer

Who this might be right for
Cervical Cancer
Inovio Pharmaceuticals 10
Next Page